The potential of the cruciform structure formation as an important factor influencing p53 sequence-specific binding to natural DNA targets

Biochemical and Biophysical Research Communications

Volumn 391, Issue 3, 2010, Pages 1409-1414

  Jagelská, Eva B ^a   Pivoňková, Hana ^a   Fojta, Miroslav ^a   Brázda, Václav ^a  

^a INSTITUTE OF BIOPHYSICS   (Czech Republic)

Author keywords

DNA binding; p53 protein; Protein DNA complex

Indexed keywords

DNA; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 45; P21 ACTIVATED KINASE; PROTEIN MDM2; PROTEIN P53;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; BINDING SITE; CELL STRESS; CONTROLLED STUDY; CRUCIFORM STRUCTURE; DNA PROTEIN COMPLEX; DNA STRUCTURE; DNA SUPERCOILING; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE TARGETING; IMMUNOPRECIPITATION; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DNA BINDING;

ANIMALS; BASE SEQUENCE; CELL LINE; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DNA, SINGLE-STRANDED; DNA, SUPERHELICAL; ELECTROPHORETIC MOBILITY SHIFT ASSAY; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; INVERTED REPEAT SEQUENCES; NUCLEIC ACID CONFORMATION; PLASMIDS; PROTO-ONCOGENE PROTEINS C-MDM2; TUMOR SUPPRESSOR PROTEIN P53;

EID: 73949090549     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.12.076     Document Type: Article

References (36)

1. Liebermann D.A., Hoffman B., and Vesely D. p53 induced growth arrest versus apoptosis and its modulation by survival cytokines. Cell Cycle 6 (2007) 166-170
2. Dey A., Verma C.S., and Lane D.P. Updates on p53: modulation of p53 degradation as a therapeutic approach. Br. J. Cancer 98 (2008) 4-8
3. Qian H., Wang T., Naumovski L., Lopez C.D., and Brachmann R.K. Groups of p53 target genes involved in specific p53 downstream effects cluster into different classes of DNA binding sites. Oncogene 21 (2002) 7901-7911
4. el-Deiry W.S., Kern S.E., Pietenpol J.A., Kinzler K.W., and Vogelstein B. Definition of a consensus binding site for p53. Nat. Genet. 1 (1992) 45-49
5. Degtyareva N., Subramanian D., and Griffith J.D. Analysis of the binding of p53 to DNAs containing mismatched and bulged bases. J. Biol. Chem. 276 (2001) 8778-8784
6. McKinney K., and Prives C. Efficient specific DNA binding by p53 requires both its central and C-terminal domains as revealed by studies with high-mobility group 1 protein. Mol. Cell. Biol. 22 (2002) 6797-6808
7. Kim E., and Deppert W. The complex interactions of p53 with target DNA: we learn as we go. Biochem. Cell Biol. 81 (2003) 141-150
8. Stros M., Muselikova-Polanska E., Pospisilova S., and Strauss F. High-affinity binding of tumor-suppressor protein p53 and HMGB1 to hemicatenated DNA loops. Biochemistry 43 (2004) 7215-7225
9. Subramanian D., and Griffith J.D. Modulation of p53 binding to Holliday junctions and 3-cytosine bulges by phosphorylation events. Biochemistry 44 (2005) 2536-2544
10. Stansel R.M., Subramanian D., and Griffith J.D. P53 binds telomeric single strand overhangs and t-loop junctions in vitro. J. Biol. Chem. 277 (2002) 11625-11628
11. Palecek E., Brazda V., Jagelska E., Pecinka P., Karlovska L., and Brazdova M. Enhancement of p53 sequence-specific binding by DNA supercoiling. Oncogene 23 (2004) 2119-2127
12. Palecek E., Brazdova M., Brazda V., Palecek J., Billova S., Subramaniam V., and Jovin T.M. Binding of p53 and its core domain to supercoiled DNA. Eur. J. Biochem. 268 (2001) 573-581
13. Brazda V., Palecek J., Pospisilova S., Vojtesek B., and Palecek E. Specific modulation of p53 binding to consensus sequence within supercoiled DNA by monoclonal antibodies. Biochem. Biophys. Res. Commun. 267 (2000) 934-939
14. Stefanovsky V.Y., and Moss T. The cruciform DNA mobility shift assay: a tool to study proteins that recognize bent DNA. Methods Mol. Biol. 543 (2009) 537-546
15. Mazina O.M., Rossi M.J., Thomaa N.H., and Mazin A.V. Interactions of human rad54 protein with branched DNA molecules. J. Biol. Chem. 282 (2007) 21068-21080
16. Brazda V., Jagelska E.B., Liao J.C., and Arrowsmith C.H. The central region of BRCA1 binds preferentially to supercoiled DNA. J. Biomol. Struct. Dyn. 27 (2009) 97-104
17. Chasovskikh S., Dimtchev A., Smulson M., and Dritschilo A. DNA transitions induced by binding of PARP-1 to cruciform structures in supercoiled plasmids. Cytometry A 68 (2005) 21-27
18. Cote A.G., and Lewis S.M. Mus81-dependent double-strand DNA breaks at in vivo-generated cruciform structures in S. cerevisiae. Mol. Cell. 31 (2008) 800-812
19. Poulet A., Buisson R., Faivre-Moskalenko C., Koelblen M., Amiard S., Montel F., Cuesta-Lopez S., Bornet O., Guerlesquin F., Godet T., Moukhtar J., Argoul F., Declais A.C., Lilley D.M., Ip S.C., West S.C., Gilson E., and Giraud-Panis M.J. TRF2 promotes, remodels and protects telomeric Holliday junctions. EMBO J. 28 (2009) 641-651
20. Kim E., Albrechtsen N., and Deppert W. DNA-conformation is an important determinant of sequence-specific DNA binding by tumor suppressor p53. Oncogene 15 (1997) 857-869
21. Jagelska E.B., Brazda V., Pecinka P., Palecek E., and Fojta M. DNA topology influences p53 sequence-specific DNA binding through structural transitions within the target sites. Biochem. J. 412 (2008) 57-63
22. Palecek E., Vlk D., Stankova V., Brazda V., Vojtesek B., Hupp T.R., Schaper A., and Jovin T.M. Tumor suppressor protein p53 binds preferentially to supercoiled DNA. Oncogene 15 (1997) 2201-2209
23. Jagelska E., Brazda V., Pospisilova S., Vojtesek B., and Palecek E. New ELISA technique for analysis of p53 protein/DNA binding properties. J. Immunol. Methods 267 (2002) 227-235
24. Singleton C.K., and Wells R.D. Relationship between superhelical density and cruciform formation in plasmid pVH51. J. Biol. Chem. 257 (1982) 6292-6295
25. Brazda V., Jagelska E.B., Fojta M., and Palecek E. Searching for target sequences by p53 protein is influenced by DNA length. Biochem. Biophys. Res. Commun. 341 (2006) 470-477
26. Fojta M., Pivonkova H., Brazdova M., Nemcova K., Palecek J., and Vojtesek B. Investigations of the supercoil-selective DNA binding of wild type p53 suggest a novel mechanism for controlling p53 function. Eur. J. Biochem. 271 (2004) 3865-3876
27. Rice P., Longden I., and Bleasby A. EMBOSS: the European Molecular Biology Open Software Suite. Trends Genet. 16 (2000) 276-277
28. Parada C.A., and Marians K.J. Mechanism of DNA A protein-dependent pBR322 DNA replication. DNA A protein-mediated trans-strand loading of the DNA B protein at the origin of pBR322 DNA. J. Biol. Chem. 266 (1991) 18895-18906
29. Palecek E., Brazdova M., Brazda V., Palecek J., Billova S., Subramaniam V., and Jovin T.M. Binding of p53 and its core domain to supercoiled DNA. Eur. J. Biochem. 268 (2001) 573-581
30. van Holde K., and Zlatanova J. Unusual DNA structures, chromatin and transcription. Bioessays 16 (1994) 59-68
31. Krasilnikov A.S., Podtelezhnikov A., Vologodskii A., and Mirkin S.M. Large-scale effects of transcriptional DNA supercoiling in vivo. J. Mol. Biol. 292 (1999) 1149-1160
32. Shlyakhtenko L.S., Hsieh P., Grigoriev M., Potaman V.N., Sinden R.R., and Lyubchenko Y.L. A cruciform structural transition provides a molecular switch for chromosome structure and dynamics. J. Mol. Biol. 296 (2000) 1169-1173
33. Gohler T., Reimann M., Cherny D., Walter K., Warnecke G., Kim E., and Deppert W. Specific interaction of p53 with target binding sites is determined by DNA conformation and is regulated by the C-terminal domain. J. Biol. Chem. 277 (2002) 41192-41203
34. Pivonkova H., Pecinka P., Ceskova P., and Fojta M. DNA modification with cisplatin affects sequence-specific DNA binding of p53 and p73 proteins in a target site-dependent manner. FEBS J. 273 (2006) 4693-4706
35. Nagaich A.K., Appella E., and Harrington R.E. DNA bending is essential for the site-specific recognition of DNA response elements by the DNA binding domain of the tumor suppressor protein p53. J. Biol. Chem. 272 (1997) 14842-14849
36. Jayaraman L., Moorthy N.C., Murthy K.G., Manley J.L., Bustin M., and Prives C. High mobility group protein-1 (HMG-1) is a unique activator of p53. Genes Dev. 12 (1998) 462-472